Disorders of the extrahepatic bile duct carry considerable morbidity and mortality. Indeed, 70% of pediatric liver transplantations are performed to treat biliary atresia 1 , while primary sclerosing cholangitis (PSC) alone accounts for 5% of liver transplantations in the United States 2 and biliary complications are the leading cause of graft failure following deceased donor liver transplantation 3, 4 . Treatment options remain limited 5, 6 owing to the lack of healthy donor tissue that can be used to reconstruct and replace diseased bile ducts. In vitro expansion of native cholangiocytes could address this limitation and provide cells suitable for tissue engineering applications such as biliary reconstruction. However, the culture of primary biliary epithelium remains problematic 7 . Here we report a new method, compatible with regenerative medicine applications, for the isolation and propagation of primary human cholangiocytes from the extrahepatic biliary tree. The resulting ECOs express key biliary markers, such as cytokeratin 7 (KRT7 or CK7), cytokeratin 19 (KRT19 or CK19), γ-glutamyl transferase (GGT) and cystic fibrosis transmembrane conductance regulator (CFTR), and maintain their functional properties in vitro, including alkaline phosphatase (ALP) and GGT activity and responses to secretin and somatostatin. The potential of ECOs in tissue engineering and clinical applications is further illustrated by their capacity to populate biodegradable scaffolds, organize into a functional biliary epithelium and rescue a mouse model of extrahepatic biliary injury (EHBI).
RESULTS

Human extrahepatic cholangiocytes can be propagated as organoids
We first focused on identifying the optimal conditions under which to isolate primary cholangiocytes from the biliary epithelium, which forms a monolayer covering the luminal surface of the biliary tree 8 . We tested several approaches for recovering these cells ( Supplementary Fig. 1a-c) ; mechanical dissociation by brushing or scraping the bile duct luminal surface was associated with improved survival of the cholangiocytes as compared to enzymatic digestion Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids of the bile duct ( Fig. 1a and Supplementary Fig. 1a) . Furthermore, the majority of the cells resulting from mechanical dissociation coexpressed the biliary markers CK7 and CK19 (94.6% ± 2.4%, s.d.; n = 3 independent dissociation experiments), and no contamination from mesenchymal cell types was detected ( Supplementary  Fig. 1d ). Consequently, mechanical dissociation constitutes the optimal method for isolating extrahepatic cholangiocytes.
To discern appropriate conditions for the maintenance and propagation of these cells, we optimized our recently established system for 3D culture of intrahepatic cholangiocytes derived from human induced pluripotent stem cells 9, 10 . Screening of multiple growth factors known to support the expansion of both cholangiocytes and epithelial organoids 11, 12 ( Supplementary Fig. 1b,c) identified the combination of epidermal growth factor (EGF), R-spondin and Dickkopf-related protein 1 (DKK-1) as sufficient to promote the growth of primary cholangiocytes into organoids ( Supplementary  Fig. 1c) . Because of the paradoxical requirement for both a Wnt potentiator (R-spondin) and a Wnt inhibitor (DKK-1), we characterized the activity of both the canonical and noncanonical (planar cell polarity, PCP) Wnt pathways in ECOs. Our results demonstrate higher β-catenin phosphorylation in ECOs than in cells treated with R-spondin but not DKK-1 ( Supplementary Fig. 1e,f) , signifying lower canonical Wnt pathway activity in these cells. Furthermore, ECOs exhibited higher Rho kinase activity than cells treated with R-spondin but not DKK-1 ( Supplementary Fig. 1g ), which could be consistent with enhanced signaling through the noncanonical PCP pathway in ECOs. Thus, it is possible that noncanonical Wnt signaling controls ECO expansion, marking a notable difference with previous organoid culture conditions 12 .
Under these conditions, we derived eight different ECO lines (Fig. 1a-d, Supplementary Figs . 2a-f and 3a-e, and Supplementary  Table 1 ) from a variety of deceased donors aged 33-77 years. Notably, we obtained similar results by using cholangiocytes isolated from the gallbladder or by isolating CBD cholangiocytes using an endoscopic retrograde cholangiopancreatography (ERCP) brush instead of scraping the luminal surface ( Supplementary Fig. 2a,b) . Consequently, ECOs can be derived from different areas of the extrahepatic biliary tree and collected using perioperative (dissection and scraping) or minimally invasive (ERCP brushing) approaches.
ECOs maintain expression of key biliary markers and functional properties in culture
The resulting cells were expanded in vitro for prolonged periods of time (Supplementary Fig. 4a ), during which they maintained their genetic stability (Supplementary Fig. 4b,c) . Electron microscopy revealed the presence of ultrastructural features characteristic of cholangiocytes, including cilia, microvilli and tight junctions 13 ( Supplementary Fig. 3c ), while qRT-PCR and immunofluorescence (IF) analyses established the expression of key biliary markers, including KRT7, KRT19, hepatocyte nuclear factor-1β (HNF-1β), GGT, secretin receptor (SCTR), sodium-dependent bile acid transporter (SLC10A2; also known as ASBT), CFTR and SRY-box 9 (SOX9) 9 ( Fig. 1b,c and Supplementary Figs. 2c,d and 3d,e) . Of note, expression was not detected for stem cell markers, such as OCT4 (POU5F1), NANOG, prominin 1 (PROM1) and leucine-rich-repeat-containing G-protein-coupled receptors (LGR family: LGR4, LGR5 and LGR6); for markers of non-biliary lineages, including albumin (ALB), α 1 -antitrypsin (A1AT; also known as SERPINA1), keratin 18 (KRT18), pancreatic and duodenal homeobox-1 (PDX1), insulin (INS) and glucagon (GCG); or for epithelial-mesenchymal transition (EMT) markers, such as vimentin (VIM), snail family transcriptional repressor 1 (SNAI1) and S100 calcium-binding protein A4 (S100A4) (Supplementary Fig. 5a-c) . On the other hand, 98.1% ± 0.9% (s.d.) of the cells (n = 3 cell lines) coexpressed CK7 and CK19 following 20 passages in culture (Supplementary Fig. 1d) , thereby confirming the presence of a nearly homogeneous population of cholangiocytes.
Transcriptomic analyses (Fig. 1d, Supplementary Fig. 6 and Supplementary Table 2) revealed that ECOs maintained a stable gene expression profile over multiple passages (Pearson correlation coefficient for passage 1 versus passage 20 ECOs, r = 0.99; Supplementary  Fig. 6a,b) , expressed key biliary markers (Supplementary Fig. 6c ) and clustered closely to freshly isolated cholangiocytes ( Supplementary  Fig. 6d ) (Pearson correlation coefficient for primary cholangiocytes versus passage 20 ECOs, r = 0.92; Supplementary Fig. 6b ). Gene ontology (GO) analyses confirmed enrichment of pathways that are typically activated in the biliary epithelium (Supplementary Fig. 6e ). When considered collectively, these results demonstrate that primary cholangiocytes derived from the extrahepatic biliary tree can be expanded in vitro without losing their original characteristics.
We then further characterized ECOs by focusing on their function following long-term culture (20 passages). Biliary epithelium regulates the homeostasis of bile through transport of ions, water and bile acids 8, 14 . The secretory capacity of ECOs was interrogated using rhodamine 123, a fluorescent substrate for the cholangiocyte surface glycoprotein multidrug resistance protein-1 (MDR1) 15, 16 ( Fig. 2a-c) . Rhodamine 123 accumulated in the ECO lumen only in the absence of the MDR1 antagonist verapamil, thereby confirming active secretion through MDR1 (Fig. 2a-c) . Luminal extrusion of bile acids 17 was also demonstrated by showing that the fluorescent bile acid cholyl-lysyl-fluorescein (CLF) was actively exported from ECOs ( Fig. 2d-f) . Furthermore, ALP and GGT activities in ECOs were comparable to those in freshly plated primary cholangiocytes (Fig. 2g,h and Supplementary Fig. 2e,f) . The response of ECOs to secretin and somatostatin was also assessed. Secretin promotes water secretion, resulting in distension of the bile duct lumen, whereas somatostatin negates the effects of secretin [18] [19] [20] . Accordingly, organoids exposed to secretin increased their diameter as compared to untreated controls, whereas somatostatin inhibited the effect of secretin (Fig. 2i,j) . Our data therefore demonstrate that ECOs maintain their functional properties after long-term culture.
ECOs self-organize into bile duct-like tubes after transplantation These results prompted us to investigate the potential of ECOs for in vivo use, especially in regenerative medicine applications. We first characterized the potential of ECOs to engraft and survive in vivo by transplanting cells under the kidney capsule of NOD.CgPrkdc scid Il2rg tm1Wjl (NSG) mice (Supplementary Fig. 7a ) and maintaining the mice for 12 weeks 21 . ECOs were successfully engrafted, forming tubular structures expressing biliary markers such as CK19 (Supplementary Fig. 7b-d) .
Notably, no tumor formation or expression of markers for differentiation into other lineages was detected (Supplementary Fig. 7d) . Thus, ECOs appear to maintain their basic characteristics even after prolonged engraftment in vivo under the kidney capsule.
ECO-populated scaffolds reconstruct the gallbladder wall
To assess the potential of ECOs for tissue engineering, we first interrogated their capacity to populate biodegradable polyglycolic acid (PGA) scaffolds, which are commonly used to provide the structural and mechanical support required for tissue reconstruction 22 . VOLUME 23 | NUMBER 8 | AUGUST 2017 nAture medicine Indeed, PGA is one of the most widely used synthetic polymers because it does not induce inflammatory responses in surrounding tissue, is biodegradable, and is more flexible and easier to process than natural polymers such as collagen 23 . To facilitate tracking of cells, ECOs expressing GFP were generated through viral transduction ( Supplementary Fig. 8 ). The resulting GFP + ECOs were seeded on PGA scaffolds where they attached to the PGA fibers within 24-48 h and continued to grow for 4 weeks until they reached confluency ( Fig. 3a-d) . Of note, primary cholangiocytes grown under 2D conditions demonstrated limited expansion potential and failed to reach confluency when seeded on the scaffolds ( Supplementary  Fig. 9 ), suggesting that the proliferative capacity of ECOs is crucial for successful scaffold colonization. The populated PGA scaffolds (Fig. 3b,c) could easily be handled with forceps and divided into smaller pieces with a surgical blade. Furthermore, the cells populating the scaffolds retained expression of biliary markers such as CK7 and CK19 (Fig. 3e,f) , demonstrated no evidence of EMT (Fig. 3e,g ) and maintained their functional properties, including ALP and GGT activity (Fig. 3h,i) . Therefore, ECOs can populate PGA scaffolds while maintaining their functionality and marker expression, thereby providing a bioengineered tissue resembling the biliary epithelium.
We then determined the capacity of ECOs to repair the biliary epithelium. To do so, we developed a mouse model of EHBI. More specifically, to simulate wall defects in the biliary tree requiring biliary reconstruction 24 , the biliary trees of healthy NSG mice were compromised by longitudinal incision of the gallbladder wall (Fig. 4a) . The surgical defect in the gallbladder wall was subsequently repaired by transplanting PGA scaffolds populated with GFP-expressing ECOs into the injured animals ( (Fig. 4b) , and post-mortem examination of these animals revealed yellow pigmentation of the peritoneal cavity and seminal vesicles, which is consistent with bile leak ( Supplementary Fig. 10a ); all animals in the group receiving fibroblast-populated scaffolds failed to reconstruct the gallbladder, which was replaced by fibrotic tissue incompatible with bile transport or storage ( Supplementary Fig. 11e-g ). In contrast, animals transplanted with ECO-populated scaffolds survived for up to 104 d without complications and were culled electively (Fig. 4b) . Notably, the reconstructed gallbladders in the group transplanted with ECO-populated scaffolds were fully remodeled, with morphology resembling that of their native (untransplanted) counterparts ( Fig. 4c and Supplementary Fig. 10b ). Histology ( Fig. 4d) , IF and qRT-PCR analyses of the ECO-reconstructed gallbladders ( Fig. 4e and Supplementary Fig. 10c,d ) demonstrated integration of GFP + ECOs expressing biliary markers such as KRT19, KRT7, HNF-1β, SOX9, CFTR and a human-specific epitope for Ku80 ( Fig. 4e and Supplementary Fig. 10c ). Of note, the IF analyses also showed the presence of mouse mesenchymal cells expressing vimentin and endothelial cells expressing CD31 in the reconstructed biliary epithelium, suggesting that the scaffold is colonized by endogenous cells after transplantation ( Supplementary Fig. 10c ). Furthermore, we also identified a population of GFP + vimentin + CK19 − cells, suggesting that ECOs may also contribute to the scaffold stroma in vivo, possibly through EMT (Supplementary Fig. 10c,e) . The integrity of the reconstructed gallbladder lumen and its exposure to bile through continuity with the biliary tree were demonstrated using magnetic resonance cholangiopancreatography (MRCP) imaging before surgery. The internal diameter of the mouse CBD is approximately 100 µm and the wall thickness is <50 µm; these dimensions precluded the use of a PGA scaffold owing to mechanical properties. Instead, we generated tubular scaffolds of densified collagen (Fig. 5a,b ) that were populated with GFP-expressing ECOs (Fig. 5c-e) . The use of densified collagen enabled the generation of constructs with an external diameter ranging from 250-600 µm and adequate strength to maintain a patent lumen (Fig. 5d) . Notably, the cells populating the collagen scaffolds maintained expression of biliary markers such as KRT19, KRT7, HNF-1β, SOX9 and CFTR (Fig. 5f,g ) and exhibited GGT and ALP enzymatic activity (Fig. 5h,i) . Primary epithelial cells of a different origin (human mammary epithelial cells, HMECs) failed to survive and adequately populate densified collagen tubes under the same conditions (Supplementary Fig. 12a ). Moreover, plated HMECs failed to survive in a 10% bile solution (Supplementary Fig.  12b ), further confirming the unique capacity of ECOs in generating bile-resistant bioengineered bile ducts. Collectively, these results demonstrate the capacity of ECOs to populate tubular densified collagen scaffolds without losing their original characteristics. We then explored the possibility of replacing the native CBD of NGS mice with a bioengineered duct consisting of an ECO-populated removal of the organ and were further confirmed with fluorescein isothiocyanate (FITC) cholangiograms (Fig. 4f,g, Supplementary  Fig. 10f and Supplementary Video 1) . Post-mortem surgical examination and full-body magnetic resonance imaging performed 104 d following transplantation showed no evidence of tumor formation ( Supplementary Fig. 10f and Supplementary Video 2) , and IF analyses showed no GFP + cells in adjacent liver tissue (data not shown). In contrast, control gallbladders reconstituted with fibroblast exhibited obliteration of the gallbladder lumen (Supplementary Fig. 11h,i) and replacement of the lumen and biliary epithelium by fibroblasts expressing the fibroblast-specific antigen S100A4 ( Supplementary  Fig. 11i,j) . When considered collectively, our findings demonstrate the capacity of ECOs to colonize their physiological niche and regenerate part of the biliary tree without any complications.
Bioengineered bile ducts replace the native mouse bile duct Reconstruction of the gallbladder wall provided proof of principle for the capacity of ECOs to repair the biliary epithelium after injury; however, in the majority of extrahepatic bile duct disorders, the CBD is affected. Therefore, we focused on the generation of a tubular ECO-populated scaffold that could be used for bile duct replacement densified collagen tube. A midportion of the native CBD was removed, and an ECO-populated collagen tube was anastomosed end to end to the proximal and distal duct remnants (Fig. 6a) . Fibroblast-populated tubes were used as a negative control. Biliary reconstruction was achieved in all animals transplanted with ECO-populated tubes (Fig. 6b,c and Supplementary Fig. 13a-d) , with mice followed up for up to 1 month post-transplantation (Supplementary Fig. 13d) . Histology, IF and qRT-PCR analyses (Fig. 6d-f and Supplementary  Fig. 13a,b) demonstrated a patent lumen, with the transplanted GFP + cells forming biliary epithelium (Fig. 6e,f and Supplementary  Fig. 13a,b) , and confirmed the expression of biliary markers such as KRT19, KRT7, HNF-1β, CFTR and SOX9 by the engrafted cells (Fig. 6d,f and Supplementary Fig. 13b ). These analyses also illustrated the presence of mouse stromal and endothelial cells (Supplementary Fig. 13b) . Moreover, we observed minimal apoptosis and proliferation in the transplanted tubes 1 month after transplantation, confirming the stability and integrity of the reconstituted biliary epithelium (Supplementary Fig. 13b,c) . Lumen patency was further confirmed by FITC cholangiogram, MRCP and serum measurements of cholestasis markers (Fig. 6g, Supplementary  Fig. 13e,f and Supplementary Video 3) . Accordingly, animals receiving ECO-populated tubes exhibited no elevation in serum levels of cholestasis markers (bilirubin and ALP; Supplementary Fig. 13e ) and showed a patent lumen on imaging ( Fig. 6g and Supplementary  Fig. 13f ), whereas bioartificial CBDs retained their ALP activity in vivo (Fig. 6h) .
In contrast, all fibroblast-populated collagen tubes failed because of lumen occlusion (Fig. 6b,c,e-g and Supplementary Fig. 13d ), resulting in high biliary pressures and bile leak through the site of anastomosis (Fig. 6b) . In conclusion, our results demonstrate the capacity of ECO-populated collagen tubes to replace the native CBD in vivo.
DISCUSSION
We have demonstrated that epithelial cells from the extrahepatic biliary tree can be expanded and propagated in vitro while maintaining their cholangiocyte transcriptional signature and functional characteristics. In addition, our results show that primary cholangiocytes expanded in vitro as organoids have a unique potential in organ regeneration. Indeed, to our knowledge, our system provides the first proof of principle for the application of regenerative medicine in the context of CBD pathology. The capacity to replace a diseased CBD with an in vitro-bioengineered ECO-populated tube could have a considerable impact on the management of disorders such as biliary atresia, which constitutes the leading cause for pediatric liver transplantation 1 , or ischemic strictures, which is one of the most common complications following transplantation 3 . Consequently, ECO-populated scaffolds represent a new system with high clinical relevance in the field of cholangiopathies.
Studies of the extrahepatic biliary epithelium have been limited by technical challenges in the long-term culture and large-scale expansion of primary cholangiocytes. These challenges have so far precluded large-scale experiments, such as transcriptomic and genome-wide analyses, which are urgently needed to better understand diseases of the bile duct such as PSC and cholangiocarcinoma. The capacity of ECOs for large-scale expansion could address this need. Indeed, we demonstrate that, starting from 10 5 extrahepatic cholangiocytes, we can generate from 10 20 -10 25 cells after 20 passages in culture. Therefore, ECOs not only represent a new source of cells for cell-based therapy but also provide a unique model system for studying the physiology and modeling disorders of the extrahepatic biliary tree in vitro.
Access to human tissue represents a considerable limitation for systems based on primary cells. However, we show that ECOs can be obtained not only from the CBD but also from the gallbladder. Gallbladder tissue is easily accessible and is routinely discarded following liver transplantation and cholecystectomy, one of the most common surgical procedures performed. Furthermore, in individuals not undergoing surgery, the CBD can be accessed using minimally invasive procedures such as ERCP, and we demonstrate that cholangiocytes can be obtained through brushings, which are routinely performed to acquire histology specimens. Notably, no morphological or functional differences were observed between organoids obtained with these different methods. Moreover, because of the scalability of our system, only a small amount of starting material is required. Finally, recent progress in replacing Matrigel with custom-made hydrogels to grow gut organoids 25 suggests that translating our system from Matrigel to a more clinically relevant good manufacturing practice (GMP)-compatible matrix could be feasible. When considered together, these approaches effectively address the challenges of tissue availability and create the possibility of cell-based therapy with autologous as well as allogeneic cells.
Notably, the derivation of primary hepatic stem cells using an organoid culture system has been reported previously 12 . However, the capacity of the resulting cells to differentiate into functional cholangiocytes and populate the biliary tree in vivo remains to be demonstrated. Furthermore, in vivo applications of such platforms could be restricted by contamination with stem cells that have a capacity to proliferate inappropriately after transplantation and/or differentiate into nonbiliary cell types. Despite the association between organoids and adult stem cells 26 , we never observed the expression of hepatocyte or pancreatic markers during our experiments, either in vitro or after transplantation, suggesting that the differentiation capacity of ECOs is limited to that of their lineage of origin. Moreover, canonical Wnt signaling, which is crucial for the expansion of adult stem cell organoids 27 , is blocked in our culture conditions through the use of DKK-1; further studies may be required to fully elucidate the role of R-spondin in our system. Considered together, these observations suggest that our culture system does not include a stem cell population. However, we cannot completely exclude the possibility that these cells could represent a biliary progenitor cell population, on the basis of their ability to self-propagate and generate organoids from single cells (Supplementary Video 4) .
Of note, we have recently established a system for the generation of cholangiocyte-like cells (CLCs) from human pluripotent stem cells 9 . However, it is worth noting that there are considerable differences between ECOs and CLCs. CLCs correspond to intrahepatic cholangiocytes, whereas ECOs represent the extrahepatic biliary epithelium. These two cell types are distinct in terms of embryological origin and disease involvement 14 , and the two systems therefore complement each other for studies of the biliary tree. Indeed, CLCs are generated following a natural path of development and maintain fetal characteristics. Therefore, they provide a unique system for studies of human biliary development and developmental diseases, which are not possible using adult cells. However, CLCs may require a period of adjustment and further maturation in vivo, whereas mature, functional cells, such as ECOs, are required for coping with biliary injury in the acute setting and may be better suited for regenerative medicine applications. Furthermore, although human induced pluripotent stem cells represent a very good source of cells capable of generating almost any tissue, the initial derivation and characterization of these cell lines remains timeconsuming and variability in differentiation capacity is still a challenge. ECOs can be derived in less than 24 h with very high efficiency and can be expanded through multiple passages without losing their original characteristics. Consequently, ECOs and CLCs are comparable in terms of scalability and are complementary in terms of applications, with the mature phenotype of ECOs providing a unique advantage for regenerative medicine applications in the context of tissue repair.
In conclusion, our results open up new avenues for the use of extrahepatic primary biliary tissue as a novel platform for in vitro studies, disease modeling and cell-based therapy applications.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
Isolation of primary cholangiocytes. Excised bile duct segments were placed in a 10-cm plate and washed once with William's E medium (Gibco, Life Technologies). A longitudinal incision was made along the wall of the excised bile duct segment, exposing the lumen, and 10-15 ml of William's E medium was added to cover the tissue. The luminal epithelium was subsequently scraped off using a surgical blade while the tissue was submerged in medium. The supernatant was collected, and the tissue and plate were washed two or three times with William's E medium to collect any remaining cells. The supernatant and washes were combined and centrifuged at 444g for 4 min. The pellet was washed with William's E medium and recentrifuged; the supernatant was discarded (Fig. 1a) .
Excised gallbladders were placed in a 15-cm plate, a longitudinal incision was made along the wall of the excised gallbladder and the lumen was washed once with William's E medium (Gibco, Life Technologies). Cholangiocytes were isolated following the method described above (Supplementary Fig. 2a) .
For cholangiocyte isolation through brushing, an excised bile duct segment was placed in a 10-cm plate and cannulated using an ERCP brush. The luminal surface was brushed 10-20 times, and the cells were collected by washing the brush several times in a Falcon tube containing 40-50 ml of William's E medium (Supplementary Fig. 2b ).
Generation and culture of ECOs. Isolated primary cholangiocytes were centrifuged at 444g for 4 min and resuspended in a mixture of 66% Matrigel (BD Biosciences, 356237) and 33% William's E medium (Gibco, Life Technologies) supplemented with 10 mM nicotinamide (Sigma-Aldrich), 17 mM sodium bicarbonate (Sigma-Aldrich), 0.2 mM 2-phospho-l-ascorbic acid trisodium salt (Sigma-Aldrich), 6.3 mM sodium pyruvate (Invitrogen), 14 mM glucose (Sigma-Aldrich), 20 mM HEPES (Invitrogen), ITS + premix (BD Biosciences), 0.1 µM dexamethasone (R&D Systems), 2 mM Glutamax (Invitrogen), 100 U/ml penicillin and 100 µg/ml streptomycin, 20 ng/ml EGF (R&D Systems), 500 ng/ml R-spondin (R&D Systems) and 100 ng/ml DKK-1 (R&D Systems). The cell suspension was plated in a 24-well plate format at 50 µl/well so that a small dome of Matrigel formed in the center of each well, and plates were then incubated at 37 °C for 10-30 min until the Matrigel solidified. Subsequently, 1 ml of William's E medium with supplements was added to each well. The culture medium was changed every 48 h.
To split the cells, Matrigel was digested by adding Cell Recovery Solution (Corning) for 30 min at 4 °C. The resulting cell suspension was collected, centrifuged at 444g for 4 min, washed once with William's E medium and resuspended in 66% Matrigel and 33% William's E medium with supplements, as described above.
All experiments were performed using passage 20 ECOs unless otherwise stated.
Cell line identity. Demographic data for the donor corresponding to each ECO line are provided in Supplementary Table 1 . Following derivation, ECO lines were authenticated by matching their karyotype (Supplementary Fig. 4b ) to the sex of the donor. The lines were tested on a regular basis and found to be negative for mycoplasma contamination.
Immunofluorescence, RNA extraction and qRT-PCR. IF analysis, RNA extraction and qRT-PCR were performed as previously described 9 . A complete list of the primary and secondary antibodies used is provided in Supplementary Table 3 . A complete list of the primers used is provided in Supplementary Table 4 .
All qRT-PCR data are presented as the median, interquartile range (IQR) and range (minimum to maximum) of four independent ECO lines unless otherwise stated. Values are given relative to that of the housekeeping gene hydroxymethylbilane synthase (HMBS). Microarrays. RNA was assessed for concentration and quality using a SpectroStar (BMG Labtech) and a Bioanalyzer (Agilent Technologies). Microarray experiments were performed at Cambridge Genomic Services, University of Cambridge, UK, using the HumanHT-12 v4 Expression BeadChip (Illumina) according to the manufacturer's instructions. Briefly, 200 ng of total RNA underwent linear amplification using the Illumina TotalPrep RNA Amplification Kit (Life Technologies) following the manufacturer's instructions. The concentration, purity and integrity of the resulting cDNA were measured by SpectroStar and Bioanalyzer. Finally, cDNA was hybridized to the HumanHT-12 v4 BeadChip overnight, and the arrays were subsequently washed, stained and scanned using the Bead Array Reader (Illumina). The RNA used for microarray analysis was collected from three different ECO lines (n = 3). Microarray experiments were performed at Cambridge Genomic Services, University of Cambridge, UK, using the HumanHT-12 v4 Expression BeadChip (Illumina) according to the manufacturer's instructions.
Microarray analysis. Raw data were loaded into R using the lumi package from Bioconductor 28 and divided into subsets according to the groups being compared; only the samples involved in a given comparison were used. Subsets were then filtered to remove any nonexpressed probes using the detection P value from Illumina. Across all samples, probes for which the intensity value was not statistically significantly different (P > 0.01) from those of the negative controls were removed from the analysis. Following filtering, the data were transformed using Variance Stabilization Transformation 29 from lumi and then normalized to remove technical variation between arrays using quantile normalization. Comparisons were performed using the limma package 30 , with results corrected for multiple testing using false discovery rate (FDR) correction. Finally, the quality of the data was assessed, along with the correlations between samples within groups.
Probes differentially expressed between hepatocytes and ECOs representing the aggregate transcriptional 'signature' of ECOs were selected for Euclidean hierarchical clustering using Perseus software (MaxQuant). Standard scores (z-scores) were calculated for the log 2 -normalized probe expression values across the different conditions and used for this analysis. Heat maps and principal-component analysis (PCA) plots were generated using MaxQuant Perseus software (http://www.perseus-framework.org/) 31 . Functional annotation and GO analyses were performed on genes that were differentially expressed between primary cholangiocytes and ECOs (Fig. 1d) using the NIAID/NIH Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.8 (https://david.ncifcrf.gov/) 32, 33 .
Western blot analysis. Total protein was extracted with lysis buffer (50 mM Tris pH 8, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100, and protease and phosphatase inhibitors). Protein concentrations were determined using the BCA Protein Assay Kit (Thermo Fisher Scientific) according to the manufacturer's instructions. Samples were prepared for western blot analysis by adding 1× NuPAGE LDS Sample Buffer with 1% β-mercaptoethanol and were incubated for 5 min at 95 °C. Protein (25 µg) was separated by 4-12% NuPAGE Bis-Tris protein gel (Invitrogen) and transferred onto polyvinylidene difluoride (PVDF) membrane (Bio-Rad). Proteins were detected by probing with antibodies specific to phospho-β-catenin (Ser33/ Ser37/Thr41) (Cell Signaling Technology, 9561), active β-catenin (Millipore, 05-665), total β-catenin (R&D, AF1329) and β-tubulin (Sigma, T4026), which was followed by incubation with horseradish-peroxidase-conjugated anti-mouse, anti-goat or anti-rabbit secondary antibodies. Membranes were developed using Pierce ECL western blotting substrate (Thermo Scientific) according to the manufacturer's instructions. The raw western blot images are provided in Supplementary Figure 14 . Validation information for each of these antibodies is available on the relevant manufacturer's website.
scaffolds. Both animals died within 24 h from bile leak; therefore, no further control experiments were performed to minimize animal discomfort.
Bile duct replacement. The native CBD was divided, and a short segment was excised. The populated densified collagen tube was anastomosed end to end, using interrupted 10-0 nylon sutures, between the divided proximal and distal CBD segments. A length of 5-0 nylon suture material (diameter, 100 µm) was inserted into the collagen tube and fed into the proximal and distal CBD segments to ensure patency of the lumen during anastomosis. After anastomosis was complete, the 5-0 suture was pushed into the duodenum through the distal bile duct and was removed through an incision in the duodenum, which was then closed with interrupted 10-0 nylon sutures. Lumen patency was assessed at the time of transplantation through light microscopy and cannulation of the lumen with a 5-0 nonabsorbable suture. Transplantation was abandoned as futile in the case of fully occluded tubes due to cell infiltration. These events were considered to represent construct failure rather than surgical complications and were therefore not censored in the survival analysis.
Bile duct ligation. C57BL/6 mice were purchased from The Jackson Laboratory. Mice were housed and bred in a Minimal Disease Unit at the animal facility at Oslo University Hospital, Rikshospitalet, Oslo, Norway. All experiments were performed on male mice aged 8-12 weeks. Median laparotomy was performed, and the CBD was exposed and ligated close to the junction of the hepatic bile ducts. Sham-operated mice underwent the same procedure without ligation. Serum was collected after 5 d. Alanine transaminase (ALT), aspartate transaminase (AST) and ALP levels were measured in serum using an ADVIA 1800 instrument (Siemens) at the Central Laboratory, Norwegian School of Veterinary Science. All animal experiments were approved by the Norwegian Food Safety Authority (project license no. FOTS 8210/15), and all animals received humane care in line with the NIH Guide for the Care and Use of Laboratory Animals.
Blood sample collection. Blood was taken using a 23-gauge needle directly from the inferior vena cava under terminal anesthesia at the time the animals were electively culled and transferred into 1.5-ml Eppendorf tubes for further processing.
Blood sample processing. Blood samples were routinely processed by the University of Cambridge Core Biochemical Assay Laboratory (CBAL). All sample analysis was performed on a Siemens Dimension EXL analyzer using reagents and assay protocols supplied by Siemens.
Light microscopy imaging. Light microscopy images of excised reconstructed gallbladders were acquired using a Leica MZFLIII fluorescence dissecting microscope. The images are representative of five animals.
Cryosectioning and histology. Excised gallbladders were fixed in 4% PFA, immersed in sucrose solution overnight, mounted in optimal cutting temperature (OCT) compound and stored at −80 °C until sectioning. Sections were cut to a thickness of 10 µm using a cryostat microtome and mounted on microscopy slides for further analysis. H&E staining. H&E staining was performed using Sigma-Aldrich reagents according to the manufacturer's instructions. Briefly, tissue sections were hydrated, treated with Meyer's hematoxylin solution for 5 min (Sigma-Aldrich), washed with warm tap water for 15 min, placed in distilled water for 30-60 s and incubated with eosin solution (Sigma-Aldrich) for 30-60 s. Sections were subsequently dehydrated and mounted using Eukitt quick-hardening mounting medium (Sigma-Aldrich). Histology sections were reviewed by an independent histopathologist with a special interest in hepatobiliary histology (S.D.).
TUNEL assay. TUNEL assays were performed using a commercially available kit (Abcam, ab66110) according to the manufacturer's instructions.
FITC cholangiography.
In situ FITC cholangiography was performed in euthanized animals after dissection of the gallbladder from adherent liver lobes but before surgical interruption of the extrahepatic biliary tree. The distal bile duct was cannulated with a 23½-gauge needle, FITC was injected in retrograde into the gallbladder and images were taken under a fluorescent microscope.
Magnetic resonance cholangiopancreatography. MRCP was performed after euthanization of the animals and was carried out at 4.7 T using a Bruker BioSpec 47/40 system. A sequence with rapid acquisition followed by relaxation enhancement was used with an echo train length of 40 echoes at 9.5-ms intervals, a repetition time of 1,000 ms and a field of view of 5.84 × 4.18 × 4.18 cm 3 with a matrix of 256 × 180 × 180 pixels, yielding an isotropic resolution of 230 µm. The actively decoupled four-channel mouse cardiac array provided by Bruker was used for imaging.
For the second mouse imaged, a 2D sequence was used with slightly varied parameters (24 echoes spaced at 11-ms intervals to give an effective echo time of 110 ms, repetition time of 5,741 ms, matrix size of 256 × 256, field of view of 4.33 × 5.35 cm 2 ; yielding a planar resolution of 170 × 200 µm 2 ) for a higher signal-to-noise ratio to improve visualization of the biliary ducts. Fifteen 0.6-mm slices were acquired coronally through the liver and gallbladder. For acquisition, a volume coil was used to reduce the impact of radiofrequency inhomogeneity.
The biliary duct and gallbladder images were prepared by maximum-intensity projection. Structural imaging to rule out neoplastic growth was performed using a T1-weighted 3D FLASH (fast low-angle shot) sequence with a flip angle of 25°, a repetition time of 14 ms and an echo time of 7 ms. The matrix was 512 × 256 × 256 with a field of view of 5.12 × 2.56 × 2.56 cm 3 , for a final isotropic resolution of 100 µm.
The MRCP images were reviewed by two independent radiologists with a special interest in hepatobiliary radiology (E.M.G. and S.U.).
Statistical analyses.
All statistical analyses were performed using GraphPad Prism 6. For small sample sizes, where descriptive statistics were not appropriate, individual data points were plotted. For comparison of two mean values, a two-sided Student's t-test was used to calculate statistical significance. Normal distribution of our values was confirmed using the D' Agostino-Pearson omnibus normality test where appropriate. Variance between samples was tested using the Brown-Forsythe test. To compare multiple groups to a reference group, oneway ANOVA with Dunnett's correction for multiple comparisons was used for groups with equal variance and the Kruskal-Wallis test with Dunn's correction for multiple comparisons was applied for groups with unequal variance. Survival was compared using log-rank (Mantel-Cox) tests. Where given, the number of replicates (n) refers to the number of ECO lines or the number of different animals, unless otherwise stated. Further details of the statistical analyses performed are provided in Supplementary Table 5 .
For animal experiments, group sizes were estimated on the basis of previous study variance. Final animal group sizes were chosen to allow elective culling at different time points while maintaining n > 4 animals surviving past 30 d to ensure reproducibility. No statistical methods were used to calculate sample size. No formal randomization method was used to assign animals to study groups. However, littermate animals from a given cage were randomly assigned to experimental or control groups by a technician not involved in the study. No animals were excluded from the analysis. No blinding was used when only one group of animals survived for radiology imaging. In cases where more than one group survived to be imaged, such as when gallbladders were reconstructed with fibroblasts versus ECOs, both radiologists reviewing the images (E.G. and S.U.) where blinded to the method of reconstruction.
Data availability. The microarray data are open access and available online on ArrayExpress under accession code E-MTAB-4591.
